New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes.

MLA

Fletcher, A., et al. “New Monoclonal Antibodies in CD59: Use for the Analysis of Peripheral Blood Cells from Paroxysmal Nocturnal Haemoglobinuria (PNH) Patients and for the Quantitation of CD59 on Normal and Decay Accelerating Factor (DAF)-Deficient Erythrocytes.” Immunology, vol. 75, no. 3, Mar. 1992, pp. 507–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1374058&authtype=sso&custid=ns315887.

APA

Fletcher, A., Bryant, J. A., Gardner, B., Judson, P. A., Spring, F. A., Parsons, S. F., Mallinson, G., & Anstee, D. J. (1992). New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes. Immunology, 75(3), 507–512.

Chicago

Fletcher, A, J A Bryant, B Gardner, P A Judson, F A Spring, S F Parsons, G Mallinson, and D J Anstee. 1992. “New Monoclonal Antibodies in CD59: Use for the Analysis of Peripheral Blood Cells from Paroxysmal Nocturnal Haemoglobinuria (PNH) Patients and for the Quantitation of CD59 on Normal and Decay Accelerating Factor (DAF)-Deficient Erythrocytes.” Immunology 75 (3): 507–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1374058&authtype=sso&custid=ns315887.